Full name
GRUPER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
49.41.Z - Road freight transport
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,7 | -0,2 | 1,9 | 1039,9 |
EBITDA | 3,7 | 0,7 | 3,6 | 384 |
Short time liabilities | 24,9 | 29,1 | 39,7 | 36,4 |
Equity capital | 1 | -0,1 | 1,3 | 2629,3 |
Operating profit (EBIT) | 2,7 | -0,3 | 2,4 | 1035,5 |
Assets | 26,8 | 30,9 | 42,9 | 39 |
Net profit (loss) | 2,2 | -0,2 | 1,4 | 799 |
Cash | 4,5 | 4,8 | 4,4 | -9,2 |
Liabilities and provisions for liabilities | 25,9 | 30,9 | 41,6 | 34,5 |
Net income from sale | 112,2 | 128,1 | 145,3 | 13,5 |
Working assets | 21,6 | 25,4 | 37,7 | 48,1 |
Depreciation | 1,1 | 1 | 1,2 | 18,1 |
% | % | % | p.p. | |
Profitability of capital | 225,9 | 376,2 | 104 | -272,2 |
Equity capital to total assets | 3,6 | -0,2 | 3,1 | 3,3 |
Gross profit margin | 2,4 | -0,2 | 1,3 | 1,5 |
EBITDA Margin | 3,3 | 0,6 | 2,5 | 1,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 81 | 83 | 100 | 17 |
Current financial liquidity indicator | 0.8588503003120422 | 0.8680567741394043 | 0.9400294423103333 | 0 |
Net dept to EBITDA | -0.9943971633911133 | -6.195349216461182 | -1.2287509441375732 | 5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane